[
  {
    "author": [
      {
        "family": "Andrews",
        "given": "N.C."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1986–95"
    ],
    "title": [
      "Disorders of iron metabolism"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Brugnara",
        "given": "C."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Crit Rev Clin Lab Sci"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "93–130"
    ],
    "title": [
      "Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Kuhn",
        "given": "L.C."
      },
      {
        "family": "Hentze",
        "given": "M.W."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "J Inorg Biochem"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "183–95"
    ],
    "title": [
      "Coordination of cellular iron metabolism by posttranscriptional gene regulation"
    ],
    "type": "article-journal",
    "volume": [
      "47"
    ]
  },
  {
    "author": [
      {
        "family": "Labbe",
        "given": "R.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Clin Chem"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "2060–72"
    ],
    "title": [
      "Zinc protoporphyrin: A metabolite with a mission"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "Rettmer",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Pediatrics"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "37"
    ],
    "title": [
      "Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Tapiero",
        "given": "H."
      },
      {
        "family": "Gate",
        "given": "L."
      },
      {
        "family": "Tew",
        "given": "K.D."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Biomed Pharmacother"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "324–32"
    ],
    "title": [
      "Iron: deficiencies and requirements"
    ],
    "type": "article-journal",
    "volume": [
      "55"
    ]
  },
  {
    "note": [
      "46 CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "given": "Y."
      }
    ],
    "citation-number": [
      "1."
    ],
    "type": null,
    "url": [
      "www.bcshguidelines.com/pdf/SICKLE.V4_0802."
    ]
  },
  {
    "author": [
      {
        "family": "Bonaventura",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Biol Chem"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "14557–63"
    ],
    "title": [
      "Heme redox properties of S-nitrosated hemoglobin A0 and hemoglobin S: implications for interactions of nitric oxide with normal and sickle red blood cells"
    ],
    "type": "article-journal",
    "volume": [
      "277"
    ]
  },
  {
    "author": [
      {
        "family": "Lottenberg",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Hematology Am Soc Hematol Educ Program"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "58–65"
    ],
    "title": [
      "An evidence-based approach to the treatment of adults with sickle cell disease"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Rees",
        "given": "D.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "744–52"
    ],
    "title": [
      "Guidelines for the management of the acute painful crisis in sickle cell disease"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Steinberg",
        "given": "M.H."
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1021–30"
    ],
    "title": [
      "Management of sickle cell disease"
    ],
    "type": "article-journal",
    "volume": [
      "340"
    ]
  },
  {
    "note": [
      "60 CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dzik",
        "given": "W.H."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Curr Opin Hematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "521–6"
    ],
    "title": [
      "Leukoreduction of blood components"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Hoffbrand",
        "given": "A.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "17–24"
    ],
    "title": [
      "Role of deferiprone in chelation therapy for transfusional iron overload"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "Olivieri",
        "given": "N.F."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "99–109"
    ],
    "title": [
      "The beta-thalassemias"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Rund",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1135–46"
    ],
    "title": [
      "Beta-thalassemia"
    ],
    "type": "article-journal",
    "volume": [
      "353"
    ]
  },
  {
    "author": [
      {
        "family": "Shalev",
        "given": "O."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "2008–13"
    ],
    "title": [
      "Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo"
    ],
    "type": "article-journal",
    "volume": [
      "86"
    ]
  },
  {
    "author": [
      {
        "family": "Weatherall",
        "given": "D.J."
      },
      {
        "family": "Provan",
        "given": "A.B."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "1169–75"
    ],
    "title": [
      "Red cells I: inherited anaemias"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "note": [
      "74 CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Antman",
        "given": "K.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Medicine (Baltimore"
    ],
    "date": [
      "1979"
    ],
    "pages": [
      "377–84"
    ],
    "title": [
      "Microangiopathic hemolytic anemia and cancer: a review"
    ],
    "type": "article-journal",
    "volume": [
      "58"
    ]
  },
  {
    "author": [
      {
        "family": "George",
        "given": "J.N."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "1223–9"
    ],
    "title": [
      "How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Moake",
        "given": "J.L."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "589–600"
    ],
    "title": [
      "Thrombotic microangiopathies"
    ],
    "type": "article-journal",
    "volume": [
      "347"
    ]
  },
  {
    "author": [
      {
        "family": "Cooper",
        "given": "R.A."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Semin Hematol"
    ],
    "date": [
      "1980"
    ],
    "pages": [
      "103–12"
    ],
    "title": [
      "Hemolytic syndromes and red cell membrane abnormalities in liver disease"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "McBride",
        "given": "J.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1970"
    ],
    "pages": [
      "383–97"
    ],
    "title": [
      "Abnormal kinetics of red cell membrane cholesterol in acanthocytes: studies in genetic and experimental abetalipoproteinaemia and in spur cell anaemia"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "note": [
      "94 CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Abkowitz",
        "given": "J.L."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Ann Intern Med"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "524–6"
    ],
    "title": [
      "Aplastic anemia: which treatment?"
    ],
    "type": "article-journal",
    "volume": [
      "135"
    ]
  },
  {
    "author": [
      {
        "family": "Young",
        "given": "N.S."
      },
      {
        "family": "Barrett",
        "given": "A.J."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "3367–77"
    ],
    "title": [
      "The treatment of severe acquired aplastic anemia"
    ],
    "type": "article-journal",
    "volume": [
      "85"
    ]
  },
  {
    "author": [
      {
        "family": "Young",
        "given": "N.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "1365–72"
    ],
    "title": [
      "The pathophysiology of acquired aplastic anemia"
    ],
    "type": "article-journal",
    "volume": [
      "336"
    ]
  },
  {
    "citation-number": [
      "100"
    ],
    "title": [
      "CHAPTER 2 Red cell disorders"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "626–9"
    ],
    "title": [
      "Proposed revised criteria for the classification of acute myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Annals of Internal Medicine"
    ],
    "date": [
      "1985"
    ],
    "pages": [
      "460–2"
    ],
    "title": [
      "Criteria for the diagnosis of acute leukaemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "British Journal of Haematology"
    ],
    "date": [
      "1991"
    ],
    "pages": [
      "325–9"
    ],
    "title": [
      "Proposals for the recognition of minimally differentiated acute myeloid leukaemia (AML-M0"
    ],
    "type": "article-journal",
    "volume": [
      "78"
    ]
  },
  {
    "author": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "World Health Organization Classification of Tumours. IARC Press"
    ],
    "title": [
      "Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Grimwade",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1312–20"
    ],
    "title": [
      "The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial"
    ],
    "type": "article-journal",
    "volume": [
      "98"
    ]
  },
  {
    "author": [
      {
        "family": "Smith",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "J Natl Cancer Inst"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "407–18"
    ],
    "title": [
      "The secondary leukemias: challenges and research directions"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Dohner",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3740–6"
    ],
    "title": [
      "Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Milligan",
        "given": "D.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "British Journal of Haematology"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "450–74"
    ],
    "title": [
      "Guidelines on the management of acute myeloid leukaemia in adults"
    ],
    "type": "article-journal",
    "volume": [
      "135"
    ]
  },
  {
    "author": [
      {
        "given": "Y."
      }
    ],
    "citation-number": [
      "9."
    ],
    "type": null,
    "url": [
      "http://www.bcshguidelines.com/fulltext/guideline.asp?id=5584"
    ]
  },
  {
    "author": [
      {
        "family": "Finiewicz",
        "given": "K.J."
      },
      {
        "family": "Larson",
        "given": "R.A."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "6–20"
    ],
    "title": [
      "Dose-intensive therapy for adult acute lymphoblastic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "author": [
      {
        "family": "Thomas",
        "given": "X."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "4075–86"
    ],
    "title": [
      "Outcome of treatment of adults with acute lymphoblastic leukaemia: analysis of the LALA-94 trial"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Pui",
        "given": "C.-H."
      },
      {
        "family": "Evans",
        "given": "W.E."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "166–78"
    ],
    "title": [
      "Treatment of acute lymphoblastic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "354"
    ]
  },
  {
    "author": [
      {
        "family": "Wassmann",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1469–77"
    ],
    "title": [
      "Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Lee",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "4014–22"
    ],
    "title": [
      "Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Larson",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "2025–37"
    ],
    "title": [
      "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811"
    ],
    "type": "article-journal",
    "volume": [
      "85"
    ]
  },
  {
    "author": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2001"
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "World Health Organization Classification of Tumours. IARC Press"
    ],
    "title": [
      "Tumours of Haematopoietic and Lymphoid Tissues"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Baccarani",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1809–20"
    ],
    "title": [
      "Evolving concepts in the management of chronic myeloid leukaemia: recommendations from an expert panel on behalf of European LeukaemiaNet"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Hughes",
        "given": "T.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1421–32 4"
    ],
    "title": [
      "Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia"
    ],
    "type": "article-journal",
    "url": [
      "www.nice.org.uk"
    ],
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "O’Brien",
        "given": "S.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "note": [
      "CHRONIC MYELOID LEUKAEMIA (CML) 149"
    ],
    "pages": [
      "994–1004"
    ],
    "title": [
      "Imatinib compared with interferon and low dose cytarabine for newly diagnosed chronic phase chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Druker",
        "given": "B.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2408–17"
    ],
    "title": [
      "Five-year follow-up of patients receiving Imatinib for chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Hughes",
        "given": "T.P."
      },
      {
        "family": "a.l",
        "particle": "et"
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "28–37"
    ],
    "title": [
      "Monitoring CML patients responding to treatment with tyrosine kinase inhibitors–recommendations for ‘harmonizing’ current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Goldman",
        "given": "J."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Y"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Recommendations for the management of BCR-ABL-positive chronic myeloid leukaemia"
    ],
    "type": "article-journal",
    "url": [
      "www.bcshguidelines.com/pdf/CML_guidelines_270707.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Hochhaus",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2303–9"
    ],
    "title": [
      "Dasatinib induces notable hemaologic and cytogenetic responses in chronic phase chronic myeloid leukaemia after failure of imatinib therapy"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Guilhot",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "4143–50"
    ],
    "title": [
      "Dasatinib induces significant hemaologic and cytogenetic responses in patients with imatinib-resistant or intolerant chronic myeloid leukaemia in accelerated phase"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Cortes",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3207–13"
    ],
    "title": [
      "Dasatinib induces complete hemaologic and cytogenetic responses in patients with imatinib-resistant or intolerant chronic myeloid leukaemia in blast crisis"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "citation-number": [
      "12."
    ],
    "date": [
      "2007"
    ],
    "publisher": [
      "NCCN Practice Guidelines"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Moreau",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Am J Clin Pathol"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "378–82"
    ],
    "title": [
      "Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Montserrat",
        "given": "E."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "279–84"
    ],
    "title": [
      "New prognostic markers in CLL"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Seiler",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "186–94"
    ],
    "title": [
      "Risk stratification in chronic lymphocytic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "33"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "4990–7"
    ],
    "title": [
      "National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "5."
    ],
    "editor": [
      {
        "family": "www",
        "given": "Y."
      }
    ],
    "pages": [
      "119 2007"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Catovsky",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "230–9"
    ],
    "title": [
      "Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the CLL4 Trial): a randomized controlled trial"
    ],
    "type": "article-journal",
    "volume": [
      "370"
    ]
  },
  {
    "author": [
      {
        "family": "Oscier",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "294–315"
    ],
    "title": [
      "Diagnosis and management of chronic lymphocytic leukaemia: A guideline"
    ],
    "type": "article-journal",
    "volume": [
      "125"
    ]
  },
  {
    "author": [
      {
        "given": "Y."
      }
    ],
    "citation-number": [
      "8."
    ],
    "type": null,
    "url": [
      "http://www.bcshguidelines.com/pdf/chronicLL_050504.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Gribben",
        "given": "J.G."
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2005",
      "2005"
    ],
    "pages": [
      "292–8"
    ],
    "title": [
      "Salvage therapy for CLL and the role of stem cell transplantation"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Montserrat",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1276–83"
    ],
    "title": [
      "How I treat refractory CLL"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Wierda",
        "given": "W."
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "285–94"
    ],
    "title": [
      "Current and investigational therapies for patients with CLL"
    ],
    "type": "article-journal"
  },
  {
    "citation-number": [
      "160"
    ],
    "container-title": [
      "CHAPTER 4 Leukaemia"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Harris",
        "given": "N.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "1361–92"
    ],
    "title": [
      "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group"
    ],
    "type": "article-journal",
    "volume": [
      "84"
    ]
  },
  {
    "author": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "WHO Classification of Tumours"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Kleihues",
        "given": "P.Sobin"
      },
      {
        "given": "L."
      }
    ],
    "location": [
      "Lyon"
    ],
    "publisher": [
      "ARC Press"
    ],
    "type": "chapter"
  },
  {
    "citation-number": [
      "3."
    ],
    "container-title": [
      "The Non-Hodgkin’s Lymphoma Classification Project",
      "Blood"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "3909–18"
    ],
    "title": [
      "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "987–94"
    ],
    "title": [
      "A predictive model for aggressive non-Hodgkin’s lymphoma. The international Non-Hodgkin’s Lymphoma Prognostic Factors"
    ],
    "type": "article-journal",
    "volume": [
      "329"
    ]
  },
  {
    "author": [
      {
        "family": "Sehn",
        "given": "L.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1857–61"
    ],
    "title": [
      "The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "P.",
        "given": "Solal-Celigny"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1258–65"
    ],
    "title": [
      "Follicular lymphoma international prognostic index"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "citation-number": [
      "186"
    ],
    "container-title": [
      "CHAPTER 5 Lymphoma"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Marcus",
        "given": "R.E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1417–23"
    ],
    "title": [
      "CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Gribben",
        "given": "J.G."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "4617–26"
    ],
    "title": [
      "Y www.nice.org.uk/guidance/index 3",
      "How I treat indolent lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Witzig",
        "given": "T.E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1103–8"
    ],
    "title": [
      "Rituximab therapy for patients with newly diagnosed, advanced stage, follicular grade I non-Hodgkin’s lymphoma: a phase II trial in North Central Cancer Treatment Group"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Hainsworth",
        "given": "J.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1088–95"
    ],
    "title": [
      "Maximising therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin’s lymphoma – a randomized phase II trial of the Minnie Pearl Cancer Research Network"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Kaminski",
        "given": "M.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "441–9"
    ],
    "title": [
      "131I-Tositumomab therapy as initial treatment for follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "352"
    ]
  },
  {
    "author": [
      {
        "family": "Press",
        "given": "O.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7"
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1606–12"
    ],
    "title": [
      "A phase 2 trial of CHOP chemotherapy followed by tositumomab/ iodine I121 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group protocol S9911"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "McLaughlin",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "2825–33"
    ],
    "title": [
      "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Oers",
        "given": "M.H.",
        "particle": "van"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3295–3301"
    ],
    "title": [
      "Rituximab maintenance improves clinical outcome of relapsed/ resistant follicular non-Hodgkin’s lymphoma, both in patients with and without rituximab during induction: results of a prospective randomized phase III intergroup trial"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Schouten",
        "given": "H.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "3918–27"
    ],
    "title": [
      "High dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma: results from the randomized European CUP trial"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Morris",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3865–71"
    ],
    "title": [
      "Outcomes after alemtuzumab-containiing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Gine",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Ann Onc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1539–45"
    ],
    "title": [
      "The Follicular Lymphoma Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Pfreundschuh",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "379–91"
    ],
    "title": [
      "CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomized controlled trial by the Mabthera International Trial (MinT) Group"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Miller",
        "given": "T.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Semin Hematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "207–12"
    ],
    "title": [
      "Diffuse aggressive histologies of non-Hodgkin lymphoma: treatment and biology of limited disease"
    ],
    "type": "article-journal",
    "volume": [
      "43"
    ]
  },
  {
    "citation-number": [
      "3."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin’s Lymphomas V.3.2007"
    ],
    "type": "chapter",
    "url": [
      "www.nccn.org"
    ]
  },
  {
    "author": [
      {
        "family": "Armitage",
        "given": "J.O."
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "29–36"
    ],
    "title": [
      "How I treat patients with diffuse large B-cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "given": "N.I.C.E."
      }
    ],
    "citation-number": [
      "5."
    ],
    "date": [
      "2003-09"
    ],
    "genre": [
      "Technology Appraisal 65,"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fisher",
        "given": "R.I."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1002–6"
    ],
    "title": [
      "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "328"
    ]
  },
  {
    "author": [
      {
        "family": "Coiffier",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "235–242"
    ],
    "title": [
      "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "346"
    ]
  },
  {
    "author": [
      {
        "family": "Feugier",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4117–26"
    ],
    "title": [
      "Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study of the Groupe d’Etude des Lymphomes de I’Adulte"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Sehn",
        "given": "L.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "5027–33"
    ],
    "title": [
      "Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Lenz",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1984–92"
    ],
    "title": [
      "Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone significantly improves response and time to treatment failure but not long term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Dreyling",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2677–84"
    ],
    "title": [
      "Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle cell lymphoma: results of a prospective randomized trial of the European MCL Network"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Greer",
        "given": "J."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "331–7"
    ],
    "title": [
      "Therapy of peripheral T/NK neoplasms"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Seam",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3507–16"
    ],
    "title": [
      "The role of FDG-PET scans in patients with lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "579–86"
    ],
    "title": [
      "Revised response criteria for malignant lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Philip",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1540–5"
    ],
    "title": [
      "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses. of chemotherapy -sensitive non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "333"
    ]
  },
  {
    "author": [
      {
        "family": "Morschhauser",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "54–8"
    ],
    "title": [
      "Efficacy and safety of Yttrium-90 ibritumomab tiuxetan in patients with relapsed and refractory diffuse large B-cell lymphoma not appropriate for autologous stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Hjalgrim",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1324–32"
    ],
    "title": [
      "Characteristics of Hodgkin’s lymphoma after infectious mononucleosis"
    ],
    "type": "article-journal",
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "Seam",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3507–16"
    ],
    "title": [
      "The role of FDG-PET scans in patients with lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Hutchings",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "52–9"
    ],
    "title": [
      "FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "A",
        "given": "Gallamini"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "475–481"
    ],
    "title": [
      "The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Sasse",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Haematologica Reports"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "19–22"
    ],
    "title": [
      "Combined modality treatment for early stage Hodgkins lymphoma: the GHSG experience"
    ],
    "type": "article-journal",
    "volume": [
      "2"
    ]
  },
  {
    "citation-number": [
      "6."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology Hodgkin Disease/Lymphoma v.1.2007. Y"
    ],
    "type": "chapter",
    "url": [
      "www.nccn.org/professionals/physician_gls/PDF/hodgkins.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Press",
        "given": "O.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "4238–44"
    ],
    "title": [
      "Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine and subtotal lymphoid irradiation for stage IA to IIA Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Noordijk",
        "given": "E.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3128–35"
    ],
    "title": [
      "Combined modality therapy for clinical stage I or II Hodgkin’s lymphoma: long-term results for the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Hagenbeek",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "note": [
      "abstract"
    ],
    "pages": [
      "676"
    ],
    "title": [
      "Three cycles of MOPP/ABV hybrid and involved field irradiation in favourable supradiaphragmatic clinical stages I-II Hodgkin’s disease: preliminary results of the EORTC-GELA H8F randomized trial in 543 patients"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Ferme",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1916–27"
    ],
    "title": [
      "Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "357"
    ]
  },
  {
    "author": [
      {
        "family": "Carde",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Lymphoma Co-operative Group J Clin Oncol"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "2258–72"
    ],
    "title": [
      "Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early stage Hodgkin’s disease: the H6 twin randomized trials from the EORTC"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Eghbali",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "abstract)."
    ],
    "pages": [
      "240"
    ],
    "title": [
      "Comparison of three radiation dose levels after EBVP regimen in favourable supradiaphragmatic clinical, stages I-II Hodgkin’s lymphoma: preliminary results of the EORTC/GELA H9-F trial"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Meyer",
        "given": "R.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4634–42"
    ],
    "title": [
      "Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin’s lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Straus",
        "given": "D.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3483–9"
    ],
    "title": [
      "Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II and IIA nonbulky Hodgkin disease"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Devita",
        "given": "V.T.",
        "suffix": "Jr"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Ann Intern Med"
    ],
    "date": [
      "1970"
    ],
    "pages": [
      "881–95"
    ],
    "title": [
      "Combination chemotherapy in the treatment of advanced Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "73"
    ]
  },
  {
    "author": [
      {
        "family": "Longo",
        "given": "D.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1986"
    ],
    "pages": [
      "1295–1306"
    ],
    "title": [
      "Twenty years of MOPP therapy for Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "citation-number": [
      "220"
    ],
    "container-title": [
      "CHAPTER 5 Lymphoma"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Bonnadonna",
        "given": "G."
      },
      {
        "family": "Santoro",
        "given": "A."
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Cancer Treatment Reviews"
    ],
    "date": [
      "1982"
    ],
    "pages": [
      "21–35"
    ],
    "title": [
      "ABVD chemotherapy in the treatment of Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Hasenclever",
        "given": "D."
      },
      {
        "family": "Diehl",
        "given": "V."
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1506–14"
    ],
    "title": [
      "A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease"
    ],
    "type": "article-journal",
    "volume": [
      "339"
    ]
  },
  {
    "author": [
      {
        "family": "Canellos",
        "given": "G.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "1478–84"
    ],
    "title": [
      "Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD"
    ],
    "type": "article-journal",
    "volume": [
      "327"
    ]
  },
  {
    "author": [
      {
        "family": "Duggan",
        "given": "D.B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "607–14"
    ],
    "title": [
      "Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "PG",
        "given": "Gobbi"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "9198–207"
    ],
    "title": [
      "ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin’s lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano linfomi"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Johnson",
        "given": "P.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "9208–18"
    ],
    "title": [
      "Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin’s lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Horning",
        "given": "S.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "630–7"
    ],
    "title": [
      "Stanford V and radiotherapy for locally extensive and advanced Hodgkin’s disease: mature results of a prospective clinical trial"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Diehl",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2386–95"
    ],
    "title": [
      "Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Andreas",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "note": [
      "abstract)."
    ],
    "pages": [
      "70"
    ],
    "title": [
      "Long-term follow up of BEACOPP escalated chemotherapy in patients with advanced Hodgkin lymphoma on behalf of the German Hodgkin Study Group"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Ballova",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "124–31"
    ],
    "title": [
      "A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin’s disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Loeffler",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "International Database on Hodgkin’s Disease Overview Study Group. J Clin Oncol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "818–29"
    ],
    "title": [
      "Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Aleman",
        "given": "B.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2396–2406"
    ],
    "title": [
      "Involved field radiotherapy for advanced Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Federico",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2320–5"
    ],
    "title": [
      "High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Josting",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "1280–6"
    ],
    "title": [
      "Prognostic factors and treatment outcome in primary progressive Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Moskowitz",
        "given": "C.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "645–52"
    ],
    "title": [
      "Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "124"
    ]
  },
  {
    "author": [
      {
        "family": "Linch",
        "given": "D.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1051–4"
    ],
    "title": [
      "Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Schmitz",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2065–71"
    ],
    "title": [
      "Aggressive conventional chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: a randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "359"
    ]
  },
  {
    "author": [
      {
        "family": "Peniket",
        "given": "A.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Bone Marrow Transplant"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "667–8"
    ],
    "title": [
      "An EBMT Registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure related mortality rate than autologous transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "31"
    ]
  },
  {
    "author": [
      {
        "family": "Peggs",
        "given": "K.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Lance,t"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1934–41"
    ],
    "title": [
      "Clinical evidence of a graft-versus-Hodgkin’s lymphoma effect after reduced-intensity allogeneic transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Ekstrand",
        "given": "B.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "4285–9"
    ],
    "title": [
      "Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "author": [
      {
        "family": "Diehl",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "776–83"
    ],
    "title": [
      "Clinical presentation, course and prognostic factors in lymphocytepredominant Hodgkin’s disease and lymphocyte-rich classical Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Y"
    ],
    "title": [
      "NCCN Practice Guidelines in Oncology: Myelodysplastic Syndromes V.2.2008"
    ],
    "type": "article-journal",
    "url": [
      "www.nccn. org/professionals/physician_gls/PDF/mds.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Bennett",
        "given": "J.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1982"
    ],
    "pages": [
      "189–99"
    ],
    "title": [
      "Proposals for the classification of the myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "51"
    ]
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2292–302"
    ],
    "title": [
      "The World Health Organization (WHO) classification of the myeloid neoplasms"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Germing",
        "given": "U."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukaemia Res"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "983–92"
    ],
    "title": [
      "Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7594–603"
    ],
    "title": [
      "Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Bowen",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1596–604"
    ],
    "title": [
      "Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 228 CHAPTER 6 Myelodysplasia"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Leukaemia Res"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "727–36"
    ],
    "title": [
      "Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference"
    ],
    "type": "article-journal",
    "volume": [
      "31"
    ]
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "P.L."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Basic Principles & Practice"
    ],
    "date": [
      "2000"
    ],
    "edition": [
      "3rd"
    ],
    "editor": [
      {
        "family": "Hoffman",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "location": [
      "New York, NY"
    ],
    "pages": [
      "1106–29"
    ],
    "publisher": [
      "Churchill Livingstone"
    ],
    "type": "chapter"
  },
  {
    "author": [
      {
        "family": "Greenberg",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "2079–88"
    ],
    "title": [
      "International scoring system for evaluating prognosis in myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Germing",
        "given": "U."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Leukaemia"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2223–31"
    ],
    "title": [
      "Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Ogata",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "3887–96"
    ],
    "title": [
      "Clinical significance of phenotype features of blasts in patients with myelodysplastic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Wells",
        "given": "D.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "394–403"
    ],
    "title": [
      "Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after haemopoietic stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7594–603"
    ],
    "title": [
      "Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1588–90"
    ],
    "title": [
      "Predicting survival and leukaemic evolution in patients with myelodysplastic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "note": [
      "236 CHAPTER 6 Myelodysplasia"
    ],
    "type": null
  },
  {
    "citation-number": [
      "1."
    ],
    "title": [
      "NCCN Practice Guidelines in Oncology: Myelodysplastic Syndromes V.2.2008 Y"
    ],
    "type": null,
    "url": [
      "www.nccn. org/professionals/physician_gls/PDF/mds.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Malcovati",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7594–7603"
    ],
    "title": [
      "Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Cutler",
        "given": "C.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "579–85"
    ],
    "title": [
      "A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes. Delayed transplantation for low risk myelodysplasia is associated with improved outcome"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Brunning",
        "given": "R.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "62–73"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Myelodysplastic syndromes",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Cazzola",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2005",
      "0769"
    ],
    "issue": [
      "Suppl 2"
    ],
    "title": [
      "ICL670, a once daily iron chelator, is effective and well tolerated in patients with myelodysplastic syndrome (MDS) and iron overload"
    ],
    "type": "article-journal",
    "volume": [
      "90"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Leukaemia Res"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "727–36"
    ],
    "title": [
      "Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference"
    ],
    "type": "article-journal",
    "volume": [
      "31"
    ]
  },
  {
    "author": [
      {
        "family": "Bowen",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "187–200"
    ],
    "title": [
      "Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "url": [
      "www.bcshguidelines.com/pdf/BJH120_02_187.pdf"
    ],
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Hellstrom-Lindberg",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1037–46"
    ],
    "title": [
      "A validated decision model for treating MDS with erythropoietin and GCSF: significant effects on quality of life"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Hellstrom-Lindberg",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "344–51"
    ],
    "title": [
      "Erythroid response to treatment with G-CSF plus erythropoietin for the anemia of patients with myelodysplastic syndromes: proposal for a predictive model"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Park",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "574–82"
    ],
    "title": [
      "Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Musto",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "204–9"
    ],
    "title": [
      "Darbepoietin-alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "128"
    ]
  },
  {
    "author": [
      {
        "family": "List",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "549–57"
    ],
    "title": [
      "Efficacy of lenalidomide in myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "352"
    ]
  },
  {
    "author": [
      {
        "family": "List",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1456–65"
    ],
    "title": [
      "Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Nimer",
        "given": "S.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2576–82"
    ],
    "title": [
      "Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Melchert",
        "given": "M."
      },
      {
        "family": "List",
        "given": "A."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "398–404"
    ],
    "title": [
      "Management of RBC-transfusion dependence"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Raza",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "86–93"
    ],
    "title": [
      "Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate 1-risk myelodysplastic syndromes with karyotypes other than deletion 5q"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Silverman",
        "given": "L.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3895–903"
    ],
    "title": [
      "Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921 and 9221 by the Cancer and Leukemia Group B"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Garcia-Manero",
        "given": "G."
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "405–11"
    ],
    "title": [
      "Modifying the epigenome as a therapeutic strategy in myelodysplasia"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Kantarjian",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1794–80"
    ],
    "title": [
      "Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Kantarjian",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "52–7"
    ],
    "title": [
      "Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Lubbert",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "349–57"
    ],
    "title": [
      "Cytogenetic responses in high risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2’-deoxycytidine"
    ],
    "type": "article-journal",
    "volume": [
      "114"
    ]
  },
  {
    "author": [
      {
        "family": "Killick",
        "given": "S.B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "6769–684"
    ],
    "title": [
      "A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low-risk’ myelodysplasia"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "author": [
      {
        "family": "Lim",
        "given": "Z."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "707"
    ],
    "title": [
      "European multi-centre study on the use of anti-thymocyte globulin in the treatment of myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "1056"
    ]
  },
  {
    "author": [
      {
        "family": "Shimamoto",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24"
    ],
    "container-title": [
      "Leuk Res"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "783–8"
    ],
    "title": [
      "Cyclosporin A therapy for patients with myelodysplastic syndrome: multicentre pilot studies in Japan"
    ],
    "type": "article-journal",
    "volume": [
      "27"
    ]
  },
  {
    "author": [
      {
        "family": "Broliden",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "667–70"
    ],
    "title": [
      "Antithymocyte globulin and cyclosporin A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Raza",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "958–65"
    ],
    "title": [
      "Thalidomide produces transfusion independence in long-standing refractory anaemias of patients with myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "98"
    ]
  },
  {
    "author": [
      {
        "family": "Vey",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "401 –2"
    ],
    "title": [
      "Trisenox (arsenic trioxide) in patients with myelodysplastic syndrome (MDS): preliminary results of a phase i/ii study"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Kuendgen",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1266–9"
    ],
    "title": [
      "Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Kurzrock",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "23"
    ],
    "title": [
      "High risk myelodysplastic syndrome(MDS): first results of international phase 2 study with oral farnesyltransferase inhibitor R115777 (ZARNESTRA"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Deeg",
        "given": "H.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Leukaemia"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "162–4"
    ],
    "title": [
      "Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Estey",
        "given": "E.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "3575–83"
    ],
    "title": [
      "Comparison of idarubicin + ara-C, fludarabine + ara-C and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation or refractory anemia with excess blasts"
    ],
    "type": "article-journal",
    "volume": [
      "98"
    ]
  },
  {
    "author": [
      {
        "family": "Oosterveld",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "81–9"
    ],
    "title": [
      "The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups"
    ],
    "type": "article-journal",
    "volume": [
      "123"
    ]
  },
  {
    "author": [
      {
        "family": "Deeg",
        "given": "H.J."
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2005",
      "2005"
    ],
    "pages": [
      "167–73"
    ],
    "title": [
      "Optimization of transplant regimens for patients with myelodysplastic syndromes"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ingram",
        "given": "W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "61–71"
    ],
    "title": [
      "Allogeneic transplantation for myelodysplastic syndrome (MDS"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Castro-Malaspina",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "1943–51"
    ],
    "title": [
      "Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Witte",
        "given": "T.",
        "particle": "de"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Semin Hematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "274–7"
    ],
    "title": [
      "Autologous stem cell transplantation in myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "44"
    ]
  },
  {
    "note": [
      "244 CHAPTER 6 Myelodysplasia"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "3671–4"
    ],
    "title": [
      "Report of an international working group to standardize response criteria for myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "96"
    ]
  },
  {
    "author": [
      {
        "family": "Cheson",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "419–25"
    ],
    "title": [
      "Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Jansen",
        "given": "A.J.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "270–4"
    ],
    "title": [
      "Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "citation-number": [
      "4."
    ],
    "container-title": [
      "NCCN Practice Guidelines in Oncology: Myelodysplastic Syndromes V.2.2008 Y"
    ],
    "type": "chapter",
    "url": [
      "www.nccn.org/professionals/physician_gls/PDF/mds.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Bowen",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "note": [
      "Y www.bcshguidelines.com/pdf/BJH120_02_187.pdf."
    ],
    "pages": [
      "187–200"
    ],
    "title": [
      "Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes"
    ],
    "type": "article-journal",
    "volume": [
      "120"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 248 CHAPTER 6 Myelodysplasia"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "46–59"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Myelodysplastic / myeloproliferative diseases",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "481–7"
    ],
    "title": [
      "Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta"
    ],
    "type": "article-journal",
    "volume": [
      "347"
    ]
  },
  {
    "author": [
      {
        "family": "Wattel",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "2480–7"
    ],
    "title": [
      "A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Kroger",
        "given": "N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "67–73"
    ],
    "title": [
      "Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT"
    ],
    "type": "article-journal",
    "volume": [
      "118"
    ]
  },
  {
    "author": [
      {
        "family": "Costello",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "225–32"
    ],
    "title": [
      "Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "55–7"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Juvenile myelomonocytic leukaemia",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Locatelli",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "410–19"
    ],
    "title": [
      "Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "46–59"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Myelodysplastic / myeloproliferative disease, unclassifiable",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Jones",
        "given": "A.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "This page intentionally left blank Chapter 7 253"
    ],
    "pages": [
      "2162–8"
    ],
    "title": [
      "Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "1"
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Vardiman",
        "given": "J.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2"
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2292–2302"
    ],
    "title": [
      "The World Health Organization (WHO) classification of the myeloid neoplasms"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferin",
        "given": "A."
      },
      {
        "family": "Gilliland",
        "given": "D.G."
      }
    ],
    "citation-number": [
      "3"
    ],
    "container-title": [
      "Cell Cycle"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "550–66"
    ],
    "title": [
      "Oncogenes in myeloproferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 256 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Nat Rev Cancer"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "673–83"
    ],
    "title": [
      "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "family": "Green",
        "given": "A.R."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2452–66"
    ],
    "title": [
      "The myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "355"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "459–68"
    ],
    "title": [
      "JAK2 exon 12 mutations in polycythaemia vera and idiopathic erythrocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "author": [
      {
        "family": "Wernig",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4274–81"
    ],
    "title": [
      "Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2446–52"
    ],
    "title": [
      "Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Carobbio",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2310–13"
    ],
    "title": [
      "Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Skoda",
        "given": "R."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "1–10"
    ],
    "title": [
      "The genetic basis of myeloproliferative disorders"
    ],
    "type": "article-journal"
  },
  {
    "note": [
      "258 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Szpurka",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2173–81"
    ],
    "title": [
      "Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Moliterno",
        "given": "A.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3913–5"
    ],
    "title": [
      "Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "date": [
      "2005",
      "1945"
    ],
    "genre": [
      "Lancet,"
    ],
    "title": [
      "Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2098–2100"
    ],
    "title": [
      "V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4039–41"
    ],
    "title": [
      "X-inactivation based clonality analysis and quantitative JAK2V617F assessment reveal an association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F–negative ET and MMM patients with clonal haematopoiesis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Buttner",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "J Invest Dermatol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1227–31"
    ],
    "title": [
      "Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviour"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Cools",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1201–14"
    ],
    "title": [
      "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic eosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 260 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Nat Rev Cancer"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "673–83"
    ],
    "title": [
      "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Marchioli",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2224–32"
    ],
    "title": [
      "Vascular and neoplastic risk in a large cohort of patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5104–11"
    ],
    "title": [
      "How I treat patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2446–52"
    ],
    "title": [
      "Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Vannucchi",
        "given": "A.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1952–9"
    ],
    "title": [
      "Prospective identification of high risk polycythemia vera patients based on JAK2 allele burden"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "note": [
      "268 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5104–11"
    ],
    "title": [
      "How I treat patients with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "114–24"
    ],
    "title": [
      "Efficacy and safety of low dose aspirin in polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "350"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "family": "Gennaro",
        "given": "L.",
        "particle": "Di"
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "331–5"
    ],
    "title": [
      "Prevention of thrombosis in polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "243–52"
    ],
    "title": [
      "Risk-adapted therapy in essential thrombocythemia and polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Cortelazzo",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1132–6"
    ],
    "title": [
      "Hydroxyurea in the treatment of patients with essential thrombocythemia at high risk of thrombosis: a prospective randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "332"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "33–45"
    ],
    "title": [
      "Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "353"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2664–70"
    ],
    "title": [
      "Acute leukemia in polycythaemia vera: an analysis of 1638 patients enrolled in a prospective observational study"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Lengfelder",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Ann Hematol"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "103–9"
    ],
    "title": [
      "Interferon alpha in the treatment of polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Silver",
        "given": "R.T."
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "451–8"
    ],
    "title": [
      "Long-term effects of the treatment of polycytemia vera with recombinant interferon alpha"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "McMullin",
        "given": "M.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "174–95"
    ],
    "title": [
      "Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines."
    ],
    "volume": [
      "130"
    ]
  },
  {
    "author": [
      {
        "family": "Budde",
        "given": "U."
      },
      {
        "family": "Genderen",
        "given": "P.J.",
        "particle": "van"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "SeminThromb Hemost"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "425–31"
    ],
    "title": [
      "Acquired von Willebrand disease in patients with high platelet counts"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Best Pract Res Clin Hematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "617–33"
    ],
    "title": [
      "Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Robinson",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1477–83"
    ],
    "title": [
      "The management and outcome of 18 pregnancies in women with polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "90"
    ]
  },
  {
    "author": [
      {
        "family": "McMullin",
        "given": "M.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "174–95"
    ],
    "title": [
      "Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "130"
    ]
  },
  {
    "note": [
      "Y"
    ],
    "type": null,
    "url": [
      "http://www.bcshguidelines.com/pdf/polycythaemia.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Johansson",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Intern Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "161–5"
    ],
    "title": [
      "Trends in the incidence of chronic Philadelphia chromosome negative (Ph–) myeloproliferative disorders in the city of Gothenberg, Sweden, during 1983–99"
    ],
    "type": "article-journal",
    "volume": [
      "256"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Kralovics",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1377–80"
    ],
    "title": [
      "Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Moliterno",
        "given": "A.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3913–15"
    ],
    "title": [
      "Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Ding",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "4198–200"
    ],
    "title": [
      "Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Wiestner",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Nat Genet"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "49–52"
    ],
    "title": [
      "An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1945–53"
    ],
    "title": [
      "Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study"
    ],
    "type": "article-journal",
    "volume": [
      "366"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "family": "Tefferi",
        "given": "A."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "275–90"
    ],
    "title": [
      "Thrombosis and haemorrhage in polycythemia vera and essential thrombocythaemia"
    ],
    "type": "article-journal",
    "volume": [
      "128"
    ]
  },
  {
    "author": [
      {
        "family": "Budde",
        "given": "U."
      },
      {
        "family": "Genderen",
        "given": "P.J.",
        "particle": "van"
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "SeminThromb Hemost"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "425–31"
    ],
    "title": [
      "Acquired von Willebrand disease in patients with high platelet counts"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Carobbio",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2310–13"
    ],
    "title": [
      "Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "243–52"
    ],
    "title": [
      "Risk-adapted therapy in essential thrombocythemia and polycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Am J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "755–61"
    ],
    "title": [
      "Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "family": "Vannucchi",
        "given": "A.M."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Thrombocytosis and thrombosis Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "363–70"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Ruggeri",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "772–7"
    ],
    "title": [
      "No treatment for low risk thrombocythaemia: results from a prospective study"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "114–24"
    ],
    "title": [
      "Efficacy and safety of low dose aspirin in poilycythemia vera"
    ],
    "type": "article-journal",
    "volume": [
      "350"
    ]
  },
  {
    "author": [
      {
        "family": "Barbui",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "215–32"
    ],
    "title": [
      "Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1220–32"
    ],
    "title": [
      "bcr/abl–negative, classic myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "family": "Green",
        "given": "A.R."
      }
    ],
    "citation-number": [
      "21."
    ],
    "date": [
      "2005"
    ],
    "issue": [
      "ematology2005"
    ],
    "pages": [
      "201–8"
    ],
    "title": [
      "Management of polycythemia vera and essential thrombocythemia"
    ],
    "type": null,
    "volume": []
  },
  {
    "author": [
      {
        "family": "Landolfi",
        "given": "R."
      },
      {
        "family": "Gennaro",
        "given": "L.",
        "particle": "Di"
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "331–5"
    ],
    "title": [
      "Prevention of thrombosis in polycythemia vera and essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "93"
    ]
  },
  {
    "author": [
      {
        "family": "McCarthy",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Transfusion"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "1245"
    ],
    "title": [
      "Erythromelalgia due to essential thrombocthemia"
    ],
    "type": "article-journal",
    "volume": [
      "42"
    ]
  },
  {
    "author": [
      {
        "family": "Cortelazzo",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "1132–6"
    ],
    "title": [
      "Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis"
    ],
    "type": "article-journal",
    "volume": [
      "332"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "33–45"
    ],
    "title": [
      "Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "353"
    ]
  },
  {
    "author": [
      {
        "family": "Finazzi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2664–70"
    ],
    "title": [
      "Acute leukemia in polycythaemia vera: an analysis of 1638 patients enrolled in a prospective observational study"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Barosi",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007",
      "1135"
    ],
    "genre": [
      "plus corrigenda 21,"
    ],
    "pages": [
      "277–80"
    ],
    "title": [
      "A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Nordic M.P.D.Study"
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Y"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Guidelines for the diagnosis and treatment of patients with polycythemia vera, essential thrombocythemia and idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "url": [
      "www.sfhem.se/filarkiv/files/vardprogram/NMPDGuidelines2007.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Barbui",
        "given": "T."
      },
      {
        "family": "Finazzi",
        "given": "G."
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2006",
      "2006"
    ],
    "pages": [
      "246–52"
    ],
    "title": [
      "Myeloproliferative disease in pregnancy and other management issues"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Passamonti",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "485–9"
    ],
    "title": [
      "Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Harrison",
        "given": "C."
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "REACTIVE THROMBOCYTOSIS (RT) 285"
    ],
    "pages": [
      "293–306"
    ],
    "title": [
      "Pregnancy and its management in the Philadelphia-negative myeloproliferative diseases"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Baxter",
        "given": "E.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1054–61"
    ],
    "title": [
      "Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "365"
    ]
  },
  {
    "author": [
      {
        "family": "Scott",
        "given": "L.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2435–7"
    ],
    "title": [
      "Progenitors homozygous for the V617F JAK2 mutation occur in most patients with polycythemia vera, but not essential thrombocythemia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "415–6"
    ],
    "title": [
      "A longitudinal study of the JAK2V617F mutation in myelofibrosis with myeloid metaplasia: analysis at two time points"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Wernig",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4274–81"
    ],
    "title": [
      "Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Campbell",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2098–100"
    ],
    "title": [
      "V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1739–43"
    ],
    "title": [
      "Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2V617F and response to erythropoietin therapy"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3472–6"
    ],
    "title": [
      "MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 118 patients"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Lasho",
        "given": "T.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "683–7"
    ],
    "title": [
      "Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time"
    ],
    "type": "article-journal",
    "volume": [
      "135"
    ]
  },
  {
    "author": [
      {
        "family": "Levine",
        "given": "R.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Nat Rev Cancer"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "673–83"
    ],
    "title": [
      "Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders"
    ],
    "type": "article-journal",
    "volume": [
      "7"
    ]
  },
  {
    "author": [
      {
        "family": "Guglielmelli",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "244–7"
    ],
    "title": [
      "GIMEMA –Italian Registry of Myelofibrosis; MPD Research Consortium. Anaemia characterizes patients with myelofibrosis harbouring Mpl mutation"
    ],
    "type": "article-journal",
    "volume": [
      "137"
    ]
  },
  {
    "author": [
      {
        "family": "Al-Assar",
        "given": "O."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "66–71"
    ],
    "title": [
      "Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Dong",
        "given": "M."
      },
      {
        "family": "Blobe",
        "given": "G.C."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "4589–96"
    ],
    "title": [
      "Role of transforming growth factor-beta in hematologic malignancies"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Massa",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "5688–95"
    ],
    "title": [
      "Circulating CD34+, CD133+ and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Thiele",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Ann Hematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "160–5"
    ],
    "title": [
      "Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Barbui",
        "given": "T."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1220–32"
    ],
    "title": [
      "bcr/abl–negative, classic myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Dingli",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1985–9"
    ],
    "title": [
      "Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Dupriez",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "1013–8"
    ],
    "title": [
      "Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system"
    ],
    "type": "article-journal",
    "volume": [
      "88"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "635–40"
    ],
    "title": [
      "Identification of ‘short-lived’ and ‘long-lived’ patients at presentation of idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "97"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "763–71"
    ],
    "title": [
      "Cytogenetic findings and their clinical relevance in myelofibrosis wioth myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Ahmed",
        "given": "A."
      },
      {
        "family": "Chang",
        "given": "C.C."
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Arch Pathol Lab Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1133–43"
    ],
    "title": [
      "Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis and prognosis"
    ],
    "type": "article-journal",
    "volume": [
      "130"
    ]
  },
  {
    "author": [
      {
        "family": "Dingli",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "623–30"
    ],
    "title": [
      "Prognosis in transplant eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Nordic M.P.D.Study"
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Y"
    ],
    "date": [
      "2007"
    ],
    "title": [
      "Guidelines for the diagnosis and treatment of patients with polycythemia vera, essential thrombocythemia and idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "url": [
      "www.sfhem.se/filarkiv/files/vardprogram/NMPDGuidelines2007.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "771–5"
    ],
    "title": [
      "Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients"
    ],
    "type": "article-journal",
    "volume": [
      "129"
    ]
  },
  {
    "author": [
      {
        "family": "Hasselbalch",
        "given": "H.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "92–9"
    ],
    "title": [
      "Successful treatment of anaemia in idiopathic myelofibrosis with recombinant human erythropoietin"
    ],
    "type": "article-journal",
    "volume": [
      "70"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "399–403"
    ],
    "title": [
      "Erythropoietin treatment of the anaemia of myelofibrosis with myeloid metaplasia: results in 20 patients and review of the literature"
    ],
    "type": "article-journal",
    "volume": [
      "127"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "184–6"
    ],
    "title": [
      "Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "134"
    ]
  },
  {
    "author": [
      {
        "family": "Cervantes",
        "given": "F."
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Eur J Haematol"
    ],
    "date": [
      "2007"
    ],
    "issue": [
      "68"
    ],
    "pages": [
      "13–17"
    ],
    "title": [
      "Myelofibrosis: biology and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2534–41"
    ],
    "title": [
      "A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1158–64"
    ],
    "title": [
      "Lenalidomide therapy in myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1158–64"
    ],
    "title": [
      "Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2v617F molecular remissions"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Arana-Yi",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Oncologist"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "929–43"
    ],
    "title": [
      "Advances in the therapy of chronic idiopathic myelofibrosis"
    ],
    "type": "article-journal",
    "volume": [
      "11"
    ]
  },
  {
    "author": [
      {
        "family": "Faoro",
        "given": "L.N."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "Eur J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "117–20"
    ],
    "title": [
      "Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "author": [
      {
        "family": "Mesa",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "361–70"
    ],
    "title": [
      "Palliative goals, patient selection and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "505–11"
    ],
    "title": [
      "Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Hoffman",
        "given": "R."
      },
      {
        "family": "Rondelli",
        "given": "D."
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "346–354"
    ],
    "title": [
      "Biology and treatment of primary myelofibrosis"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Guardiola",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "659"
    ],
    "title": [
      "Myelofibrosis with myeloid metaplasia"
    ],
    "type": "article-journal",
    "volume": [
      "343"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 298 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Imbert",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "27–8"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Chronic neutrophilic leukaemia",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Bohm",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Pathol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "292–5"
    ],
    "title": [
      "Evidence of clonality in chronic neutrophilic leukaemia"
    ],
    "type": "article-journal",
    "volume": [
      "56"
    ]
  },
  {
    "author": [
      {
        "family": "Reilly",
        "given": "J.T."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "10–18"
    ],
    "title": [
      "Chronic neutrophilic leukaemia: a distinct clinical entity?"
    ],
    "type": "article-journal",
    "volume": [
      "116"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "553–63"
    ],
    "title": [
      "Atypical myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "35–40"
    ],
    "title": [
      "Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study"
    ],
    "type": "article-journal",
    "volume": [
      "15"
    ]
  },
  {
    "author": [
      {
        "family": "Hasle",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "628–30"
    ],
    "title": [
      "Chronic neutrophilic leukaemia in adolesence and young adulthood"
    ],
    "type": "article-journal",
    "volume": [
      "9"
    ]
  },
  {
    "author": [
      {
        "family": "Pilotis",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2051–4"
    ],
    "title": [
      "Allogeneic bone marrow transplantation in the management of chronic neutrophilic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "43"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Cools",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1201–14"
    ],
    "title": [
      "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic eosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "P",
        "given": "Vandenberghe"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "734–42"
    ],
    "title": [
      "Clinical and molecular features of FIP1L1-PDGFRA (+) chronic eosinophilic leukemias"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Pardanani",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3038–45"
    ],
    "title": [
      "FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlatesin 89 consecutive patients with moderate to severe eosinophilia"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Trempat",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Oncogene"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "5702–6"
    ],
    "title": [
      "Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "553–63"
    ],
    "title": [
      "Atypical myeloproliferative disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Elliot",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1027–9"
    ],
    "title": [
      "Immmunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Klion",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "473–8"
    ],
    "title": [
      "Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Steer",
        "given": "E.J."
      },
      {
        "family": "Cross",
        "given": "N.C."
      }
    ],
    "citation-number": [
      "9."
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "107,113–22"
    ],
    "publisher": [
      "Acta Haematol"
    ],
    "title": [
      "Myeloproliferative disorders with translocations of chromosome 5q31–35: role of the platelet-derived growth factor beta"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Apperley",
        "given": "J.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "481–7"
    ],
    "title": [
      "Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta"
    ],
    "type": "article-journal",
    "volume": [
      "347"
    ]
  },
  {
    "author": [
      {
        "family": "Macdonald",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Acta Haematol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "101–7"
    ],
    "title": [
      "The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "133–7"
    ],
    "title": [
      "The idiopathic hypereosinophilic syndrome and eosinophilic leukemias"
    ],
    "type": "article-journal",
    "volume": [
      "89"
    ]
  },
  {
    "author": [
      {
        "family": "Simon",
        "given": "H.U."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1112–20"
    ],
    "title": [
      "Abnormal clones of interleukin-5-producing T cells in idiopathic eosinophilia"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Klion",
        "given": "A.D."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2005",
      "2005"
    ],
    "pages": [
      "209–14"
    ],
    "title": [
      "Recent advances in the diagnosis and treatment of hypereosinophilic syndromes"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Bain",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "29–31"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Chronic eosinophilic leukaemia and the hypereosinophilic syndrome",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Gleich",
        "given": "G.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1984"
    ],
    "pages": [
      "1621–6"
    ],
    "title": [
      "Episodic angioedema associated with eosinbophilia"
    ],
    "type": "article-journal",
    "volume": [
      "310"
    ]
  },
  {
    "author": [
      {
        "family": "Gotlib",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "2879–91"
    ],
    "title": [
      "The FIP1L1-PDGFRA fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification and management"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Butterfield",
        "given": "J.H."
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Acta Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "26–40"
    ],
    "title": [
      "Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "114"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Conference Report of “Year 2000 Working Confer4ence on Mastocytosis. Leuk Res"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "603–25"
    ],
    "title": [
      "Diagnostic criteria and classification of mastocytosis: a consensus proposal"
    ],
    "type": "paper-conference",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "291–302"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Mastocytosis (mast cell disease",
      "World Health Organisation classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "C",
        "given": "Buttner"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "J Invest Dermatol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1227–31"
    ],
    "title": [
      "Identification of activating c-kit mutations in adult-, but not in childhoodonset indolent mastocytosis: a possible explanation for divergent clinical behaviour"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Fritsche-Polanz",
        "given": "R."
      },
      {
        "others": true
      },
      {
        "family": "Orfao",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol",
      "Br J Haematol"
    ],
    "date": [
      "2001",
      "2007"
    ],
    "pages": [
      "357–64 5",
      "12–30"
    ],
    "title": [
      "Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis",
      "Recent advances in the understanding of mastocytosis: the role of KIT mutations"
    ],
    "type": "article-journal",
    "volume": [
      "113",
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Eur J Clin Invest"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "435–53"
    ],
    "title": [
      "Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Wolff",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Leuk Res"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "519–28"
    ],
    "title": [
      "Clinical and histopathological aspects of cutaneous mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Horny",
        "given": "H.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Pathobiology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "121–32"
    ],
    "title": [
      "Mastocytosis: state of the art"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "note": [
      "310 CHAPTER 7 Myeloproliferative neoplasms"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Pathology and genetics. Tumours of haematopoietic and lymphoid tissues"
    ],
    "date": [
      "2001"
    ],
    "editor": [
      {
        "family": "Jaffe",
        "given": "E.S."
      },
      {
        "others": true
      }
    ],
    "location": [
      "Lyon"
    ],
    "pages": [
      "291–302"
    ],
    "publisher": [
      "IARC Press"
    ],
    "title": [
      "Mastocytosis (mast cell disease",
      "World Health Organization classification of tumours"
    ],
    "type": "article-journal",
    "volume": [
      "1"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Eur J Clin Invest"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "435–53"
    ],
    "title": [
      "Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria"
    ],
    "type": "article-journal",
    "volume": [
      "37"
    ]
  },
  {
    "author": [
      {
        "family": "Valent",
        "given": "P."
      },
      {
        "family": "Metcalfe",
        "given": "D.D."
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2004",
      "2004"
    ],
    "pages": [
      "153–62"
    ],
    "title": [
      "Mast cell proliferative disorders: diagnosis, classification and therapy"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Horny",
        "given": "H.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Pathobiology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "121–32"
    ],
    "title": [
      "Mastocytosis: state of the art"
    ],
    "type": "article-journal",
    "volume": [
      "74"
    ]
  },
  {
    "author": [
      {
        "family": "Tefferi",
        "given": "A."
      },
      {
        "family": "Vardiman",
        "given": "J.W."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "14–22"
    ],
    "title": [
      "Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Orfao",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "12–30"
    ],
    "title": [
      "Recent advances in the understanding of mastocytosis: the role of KIT mutations"
    ],
    "type": "article-journal",
    "volume": [
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Kluin-Nelemans",
        "given": "H.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "4270–6"
    ],
    "title": [
      "Cladribine therapy for systemic mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "Damaj",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2008"
    ],
    "note": [
      "MPNS-UNCLASSIFIABLE (MPN-U) 317"
    ],
    "pages": [
      "249–53"
    ],
    "title": [
      "Thalidomide in advanced mastocytosis"
    ],
    "type": "article-journal",
    "volume": [
      "141"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "812–7"
    ],
    "title": [
      "Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "family": "Rajkumar",
        "given": "S.V."
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Best Pract Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "637–64"
    ],
    "title": [
      "Epidemiology of the plasma cell disorders"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1362–9"
    ],
    "title": [
      "Prevalence of monoclonal gammopathy of undetermined significance"
    ],
    "type": "article-journal",
    "volume": [
      "354"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "564–69"
    ],
    "title": [
      "A long-term study of prognosis in monoclonal gammopathy of undetermined significance"
    ],
    "type": "article-journal",
    "volume": [
      "346"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Mayo Clinic Proceedings"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "859–66"
    ],
    "title": [
      "Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "Morris Brown",
        "given": "L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3388–94"
    ],
    "title": [
      "Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory and allergic disorders"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Chng",
        "given": "W.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Best Practice and Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "571–96"
    ],
    "title": [
      "Genetic events in the pathogenesis of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "255–65"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "citation-number": [
      "326"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "The Hematology Journal"
    ],
    "date": [
      "2003"
    ],
    "issue": [
      "1"
    ],
    "pages": [
      "31–2"
    ],
    "title": [
      "Risk factors for early progression of asymptomatic multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "4"
    ]
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "785–9"
    ],
    "title": [
      "Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asaymptomatic) multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood Reviews"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "255–65"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2582–90"
    ],
    "title": [
      "Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "family": "Rajkumar",
        "given": "S.V."
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Best Practice & Research Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "637–64"
    ],
    "title": [
      "Epidemiology of the plasma cell disorders"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Chn",
        "given": "g W.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Best Practice & Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "571–96"
    ],
    "title": [
      "Genetic events in the pathogenesis of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Podar",
        "given": "K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Best Practice & Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "597–612"
    ],
    "title": [
      "The malignant clone and the bone-marrow environment"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Forum",
        "given": "U.K.Myeloma"
      },
      {
        "family": "Group",
        "given": "Nordic Myeloma Study"
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "132,410–51"
    ],
    "title": [
      "Guidelines on the diagnosis and management of multiple myeloma 2005"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/multiplemyeloma0206.pdf"
    ]
  },
  {
    "citation-number": [
      "5."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology Multiple Myeloma V.2.2008 Y"
    ],
    "type": "chapter",
    "url": [
      "http://www.nccn.org/professionals/physician_gls/PDF/myeloma.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "D’Sa",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2007"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "49–63"
    ],
    "title": [
      "Guidelines for the use of imaging in the management of myeloma"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/myeloma_management_guidelines.pdf"
    ],
    "volume": [
      "137"
    ]
  },
  {
    "author": [
      {
        "family": "Pratt",
        "given": "G."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "413–22"
    ],
    "title": [
      "The evolving use of serum free light chain assays in haematology"
    ],
    "type": "article-journal",
    "volume": [
      "141"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "family": "Avet-Loiseau",
        "given": "H."
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Best Practice and Res Clin Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "625–35"
    ],
    "title": [
      "Role of genetics in prognostication in myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Durie",
        "given": "B.G."
      },
      {
        "family": "Salmon",
        "given": "S.E."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "1975"
    ],
    "pages": [
      "842–54"
    ],
    "title": [
      "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival"
    ],
    "type": "article-journal",
    "volume": [
      "36"
    ]
  },
  {
    "author": [
      {
        "family": "Bataille",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "733–7"
    ],
    "title": [
      "C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Greipp",
        "given": "P.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3412–20"
    ],
    "title": [
      "International staging system for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Avet-Loiseau",
        "given": "H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3489–95"
    ],
    "title": [
      "Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "citation-number": [
      "356"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "323–41"
    ],
    "title": [
      "Treatment of newly diagnosed multiple myeloma based on Mayo stratification of myeloma and risk-adapted therapy (mSMART): consensus statement"
    ],
    "type": "article-journal",
    "volume": [
      "82"
    ]
  },
  {
    "author": [
      {
        "literal": "Shaughnessy, Jr J.D. et al."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2276–84"
    ],
    "title": [
      "A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Bladé",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1115–23"
    ],
    "title": [
      "Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high dose therapy and haemopoietic stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "102"
    ]
  },
  {
    "author": [
      {
        "family": "Durie",
        "given": "B.G.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2006",
      "1467"
    ],
    "title": [
      "International uniform response criteria for multiple myeloma"
    ],
    "type": "article-journal"
  },
  {
    "author": [
      {
        "family": "Forum",
        "given": "U.K.Myeloma"
      },
      {
        "family": "Group",
        "given": "Nordic Myeloma Study"
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "410–51"
    ],
    "title": [
      "Guidelines on the diagnosis and management of multiple myeloma 2005"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/multiplemyeloma0206.pdf"
    ],
    "volume": [
      "132"
    ]
  },
  {
    "author": [
      {
        "family": "Bergsagel",
        "given": "D.E."
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Baillieres Clin Haematol"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "783–94"
    ],
    "title": [
      "The role of chemotherapy in the treatment of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "825–31"
    ],
    "title": [
      "Oral melphalan and prednisolone chemotherapy plus thalidomide compared with melphalan and prednisolone alone in elderly patients with multiple myeloma: randomized controlled trial"
    ],
    "type": "article-journal",
    "volume": [
      "367"
    ]
  },
  {
    "author": [
      {
        "family": "Facon",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "21."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1209–18"
    ],
    "title": [
      "Melphalan and prednisolone plus thalidomide versus melphalan and prednisolone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "370"
    ]
  },
  {
    "author": [
      {
        "family": "Mateos",
        "given": "M.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2165–72"
    ],
    "title": [
      "Bortezomib plus melphalan and prednisolone in elderly untreated patients with multiple myeloma: results of a multicentre phase 1/2 study"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "San Miguel",
        "given": "J.F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "23."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "A phase 3 study comparing bortezomib-melphalan-prednisolone (VMP) with melphalan-prednisolone (MP) in newly diagnosed multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "24."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "4459–65"
    ],
    "title": [
      "Melphalan, predsisolone and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA-Italian Multiple Myeloma Network"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "MacLennan",
        "given": "I.C.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "25."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "200–5"
    ],
    "title": [
      "Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis"
    ],
    "type": "article-journal",
    "volume": [
      "339"
    ]
  },
  {
    "author": [
      {
        "family": "Alexanian",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "26."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1992"
    ],
    "pages": [
      "887–90"
    ],
    "title": [
      "Primary dexamethasone treatment of multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "80"
    ]
  },
  {
    "author": [
      {
        "family": "Kumar",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "27."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "432"
    ],
    "title": [
      "Single agent dexamethasone for induction in patients with multiple myeloma undergoing autologous stem cell transplants"
    ],
    "type": "article-journal",
    "volume": [
      "100"
    ]
  },
  {
    "author": [
      {
        "family": "Cavo",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "28."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "35–9"
    ],
    "title": [
      "Superiority of thalidomide and dexamethasone over vincristinedoxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "29."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "431–6"
    ],
    "title": [
      "Phase III clinical trial of thalidomise plus dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial conducted by the Eastern Cooperative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "24"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "30."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "3050–3"
    ],
    "title": [
      "Combination therapy with lenalidamide plus dexamethasone (Rev/ Dex) for newly diagnosed myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "31."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "31"
    ],
    "title": [
      "A randomized trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma: a trial co-ordinated by the Eastern Co-operative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Jagannath",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "32."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "238"
    ],
    "title": [
      "Long term follow-up of patients treated with bortzomib alone and in combination with dexamethasone as frontline therapy for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Orlowski",
        "given": "R.Z."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "33."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3892–901"
    ],
    "title": [
      "Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Harousseau",
        "given": "J.L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "34."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "139"
    ],
    "title": [
      "Velcade/dexamethasone (Vel/D) versus VAD as induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (MM): updated results of the IFM 2005/01 trial"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Cavo",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "35."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "30"
    ],
    "title": [
      "Bortezomib (Velcade)-thalidomide-dexamethasone (VTD) vs thalidomide-dexamethasone (TD) in preparation for autologous stem cell (SC) transplantation (ASCT) in newly diagnosed multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Wang",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "36."
    ],
    "container-title": [
      "Hematology"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "235–9"
    ],
    "title": [
      "Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "author": [
      {
        "family": "Popat",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "37."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "512–16"
    ],
    "title": [
      "Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multiple myeloma: updated results after long-term follow-up"
    ],
    "type": "article-journal",
    "volume": [
      "141"
    ]
  },
  {
    "author": [
      {
        "family": "Richardson",
        "given": "P.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "38."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "459 8520"
    ],
    "title": [
      "Safety and efficacy of lenalidomide (len), bortezomib (Bz) and dexamethasone (Dex) in patients with newly diagnosed multiple myeloma: a phase I/II study"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "McCloskey",
        "given": "E.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "39."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1035–43"
    ],
    "title": [
      "Long-term follow-up of a prospective, ouble-bind, placebo-controlled randomized trial of clodronate in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Berenson",
        "given": "J.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "40."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "593–602"
    ],
    "title": [
      "Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Berenson",
        "given": "J.R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "41."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1191–1200"
    ],
    "title": [
      "Zoledronic acid reduces skeletal events in patients with osteolytic metastases"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "42."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2464–72"
    ],
    "title": [
      "American Society of Clinical Oncology 2007 clinical practice update on the role of bisphosphonates in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "43."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "414–23"
    ],
    "title": [
      "Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "22"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "44."
    ],
    "container-title": [
      "Intergroupe Francais du Myelome. N Engl J Med"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "91–7"
    ],
    "title": [
      "A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "335"
    ]
  },
  {
    "author": [
      {
        "family": "Child",
        "given": "J.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "45."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "1875–83"
    ],
    "title": [
      "High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "author": [
      {
        "family": "Moreau",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "46."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "731–5"
    ],
    "title": [
      "Comparison of 200mg/m2 melphalan and 8Gy total body irradiation plus 140mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "47."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2495–2502"
    ],
    "title": [
      "Single versus double autologous stem cell transplantation for multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "349"
    ]
  },
  {
    "author": [
      {
        "family": "Fermand",
        "given": "J.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "48."
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "3131–6"
    ],
    "title": [
      "High dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial Blood"
    ],
    "type": null,
    "volume": [
      "92"
    ]
  },
  {
    "author": [
      {
        "family": "Garban",
        "given": "F."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "49."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3474–80"
    ],
    "title": [
      "Prospective comparison of autologous stem cell transplantation followed by dose reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04) in high risk de novo multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "author": [
      {
        "family": "Kröger",
        "given": "N."
      }
    ],
    "citation-number": [
      "50."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "813–21"
    ],
    "title": [
      "Autologous-allogeneic tandem stem cell transplantation in patients with multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "46"
    ]
  },
  {
    "author": [
      {
        "family": "Crawley",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "51."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4532–9"
    ],
    "title": [
      "Outcome for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors for the Chronic Leukemia Working Party of the EBMT"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "Myeloma Trialists’ Collaborative"
      }
    ],
    "citation-number": [
      "52."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "1020–34"
    ],
    "title": [
      "Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomised trials and 4012 patients"
    ],
    "type": "article-journal",
    "volume": [
      "113"
    ]
  },
  {
    "author": [
      {
        "family": "Attal",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "53."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3289–94"
    ],
    "title": [
      "Maintenance therapy with thalidomide improves survival in patients with multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Kumar",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "54."
    ],
    "container-title": [
      "Bone Marrow Transplantation"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "161–7"
    ],
    "title": [
      "High dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy"
    ],
    "type": "article-journal",
    "volume": [
      "34"
    ]
  },
  {
    "author": [
      {
        "family": "Singhal",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "55."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "1565–71"
    ],
    "title": [
      "Antitumor activity of thalidomide in refractory multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "56."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "897–901"
    ],
    "title": [
      "Thalidomide in the treatment of relapsed multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "75"
    ]
  },
  {
    "author": [
      {
        "family": "Glasmacher",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "57."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "584–93"
    ],
    "title": [
      "A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "132"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "58."
    ],
    "container-title": [
      "Hematol J"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "318–24"
    ],
    "title": [
      "Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "59."
    ],
    "container-title": [
      "Hematol J"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "112–17"
    ],
    "title": [
      "Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Offidani",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "60."
    ],
    "container-title": [
      "Haematologica"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "133–6"
    ],
    "title": [
      "Low dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective multicenter, phase II study"
    ],
    "type": "article-journal",
    "volume": [
      "91"
    ]
  },
  {
    "author": [
      {
        "family": "Hussein",
        "given": "M.A."
      }
    ],
    "citation-number": [
      "61."
    ],
    "container-title": [
      "Thromb Haemost"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "924–30"
    ],
    "title": [
      "Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations"
    ],
    "type": "article-journal",
    "volume": [
      "95"
    ]
  },
  {
    "author": [
      {
        "family": "Palumbo",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "62."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "3968–77"
    ],
    "title": [
      "Thalidomide for treatment of multiple myeloma: 10 years later"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Richardson",
        "given": "P.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "63."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2487–98"
    ],
    "title": [
      "Bortezomib or high dose dexamethasone for relapsed multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "352"
    ]
  },
  {
    "citation-number": [
      "358"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Harousseau",
        "given": "J.-L."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "64."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "issue": [
      "18"
    ],
    "pages": [
      "8002"
    ],
    "title": [
      "Effect of the combination of pegylated liposomal doxorubicin and bortezomib on time to progression of patients with relapsed/refractory multiple myeloma compared with bortezomib alone"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "author": [
      {
        "family": "Jagannath",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "65."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "165–72"
    ],
    "title": [
      "A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "127"
    ]
  },
  {
    "author": [
      {
        "family": "Richardson",
        "given": "P.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "66."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3557–60"
    ],
    "title": [
      "Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Richardson",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "67."
    ],
    "date": [
      "2007",
      "2007"
    ],
    "pages": [
      "317–23"
    ],
    "title": [
      "The treatment of relapsed and refractory multiple myeloma Hematology"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "68."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2123–32"
    ],
    "title": [
      "Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma"
    ],
    "type": "article-journal",
    "volume": [
      "357"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "D.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "69."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2133–42"
    ],
    "title": [
      "Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America"
    ],
    "type": "article-journal",
    "volume": [
      "357"
    ]
  },
  {
    "author": [
      {
        "family": "Kumar",
        "given": "S.K."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "70."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "2516–20"
    ],
    "title": [
      "Improved survival in multiple myeloma and the impact of novel therapies"
    ],
    "type": "article-journal",
    "volume": [
      "111"
    ]
  },
  {
    "author": [
      {
        "family": "Tedeschi",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood Rev"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "183–200"
    ],
    "title": [
      "Cryoglobulinaemia"
    ],
    "type": "article-journal",
    "volume": [
      "21"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 362 CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Group",
        "given": "International Myeloma Working"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "749–57"
    ],
    "title": [
      "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group"
    ],
    "type": "article-journal",
    "volume": [
      "121"
    ]
  },
  {
    "author": [
      {
        "given": "B.C.S.H./U.K.M.F."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2004"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "717–26"
    ],
    "title": [
      "Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/Plasmacytoma080304.pdf"
    ],
    "volume": [
      "124"
    ]
  },
  {
    "author": [
      {
        "family": "Liebross",
        "given": "R.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Int J Radiat Oncol Biol Phys"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "1063–7"
    ],
    "title": [
      "Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy"
    ],
    "type": "article-journal",
    "volume": [
      "41"
    ]
  },
  {
    "author": [
      {
        "family": "Tsang",
        "given": "R.W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Int J Radiat Oncol Biol Phys"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "113–20"
    ],
    "title": [
      "Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome"
    ],
    "type": "article-journal",
    "volume": [
      "50"
    ]
  },
  {
    "author": [
      {
        "family": "Alexiou",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "2305–14"
    ],
    "title": [
      "Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts"
    ],
    "type": "article-journal",
    "volume": [
      "85"
    ]
  },
  {
    "citation-number": [
      "366"
    ],
    "genre": [
      "CHAPTER 8 Paraproteinaemias"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Owen",
        "given": "R.G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "30,110–115"
    ],
    "publisher": [
      "Semin Oncol"
    ],
    "title": [
      "Clinicopathological definition of Waldenström’s macroglobulinaemia"
    ],
    "type": "book"
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "693–703"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis and related plasma cell disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Morel",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "42"
    ],
    "title": [
      "International prognostic scoring system (IPSS) for Waldenström’s macroglobulinaemia (WM"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Kimby",
        "given": "E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Clinical Lymphoma and Myeloma"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "380–3"
    ],
    "title": [
      "Update on recommendations for assessing response from the Third International Workshop on Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Buskard",
        "given": "N.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Can Med Assoc J"
    ],
    "date": [
      "1977"
    ],
    "pages": [
      "135–7"
    ],
    "title": [
      "Plasma exchange in the long-term management of Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "117"
    ]
  },
  {
    "author": [
      {
        "literal": "Johnson, .SA. et al."
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2006"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "683–97"
    ],
    "title": [
      "Guidelines on the management of Waldenström macroglobulinaemia"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/waldenstroms_"
    ],
    "volume": [
      "132"
    ]
  },
  {
    "author": [
      {
        "family": "Fonseca",
        "given": "R."
      },
      {
        "family": "Hayman",
        "given": "S."
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "700–20"
    ],
    "title": [
      "Waldenström macroglobulinaemia"
    ],
    "type": "article-journal",
    "volume": [
      "138"
    ]
  },
  {
    "author": [
      {
        "family": "Vijay",
        "given": "A."
      },
      {
        "family": "Gertz",
        "given": "M."
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "5096–103"
    ],
    "title": [
      "Waldenström macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2327–33"
    ],
    "title": [
      "Treatment of Waldenström’s macroglobulinemia with rituximab"
    ],
    "type": "article-journal",
    "volume": [
      "20"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "132–8"
    ],
    "title": [
      "Extended rituximab therapy in Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "literal": "Treon, .SP. et al."
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Clinical Lymphoma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "273–7"
    ],
    "title": [
      "CHOP plus rituximab therapy in Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "5"
    ]
  },
  {
    "author": [
      {
        "family": "Tamburini",
        "given": "J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Leukemia"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1831–4"
    ],
    "title": [
      "Fludarabine plus cyclophosphamide in Waldenström’s macroglobulinemia: results in 49 patients"
    ],
    "type": "article-journal",
    "volume": [
      "19"
    ]
  },
  {
    "author": [
      {
        "family": "Tam",
        "given": "C.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2412–20"
    ],
    "title": [
      "Fludarabine, cyclophosphamide and rituximab for the treatment of chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "author": [
      {
        "family": "Hensel",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Clin Lymphoma Myeloma"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "131–5"
    ],
    "title": [
      "Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenström’s macroglobulinemia/lymphoplasmacytic lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Weber",
        "given": "D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "note": [
      "WALDENSTRÖM MACROGLOBULINAEMIA (WM) 377"
    ],
    "pages": [
      "243–7"
    ],
    "title": [
      "2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenström‘s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "16."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "2765"
    ],
    "title": [
      "Bortezomib, dexamethasone and rituximab (BDR) is a highly active regimen in the primary therapy of Waldenström’s macroglobulinemia: planned interim results of WMCTG Clinical Trial 05-180"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "17."
    ],
    "container-title": [
      "Clin Cancer Res"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3320–5"
    ],
    "title": [
      "Multicentre clinical trial of bortezomib in relapsed/refractory Waldenström’s macroglobulinemia: results of WMCTG Trial 03-248"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Dimopoulos",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "18."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "265–9"
    ],
    "title": [
      "Treatment of Waldenström’s macroglobulinemia with singleagent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Anagnostopoulos",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "19."
    ],
    "container-title": [
      "Biol Blood Marrow Transplant"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "845–54"
    ],
    "title": [
      "Autologous or allogeneic stem cell transplantation in patients with Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "author": [
      {
        "family": "Treon",
        "given": "S.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "20."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "3442–6"
    ],
    "title": [
      "Update on treatment recommendations from the Third International Workshop on Waldenström’s macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "107"
    ]
  },
  {
    "citation-number": [
      "21."
    ],
    "container-title": [
      "NCCN Clinical Practice Guidelines in Oncology Multiple Myeloma V.2.2008. Y"
    ],
    "type": "chapter",
    "url": [
      "http://www.nccn.org/professionals/physician_gls/PDF/myeloma.pdf"
    ]
  },
  {
    "author": [
      {
        "family": "Kyle",
        "given": "R.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "22."
    ],
    "container-title": [
      "Semin Oncol"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "116–120"
    ],
    "title": [
      "Prognostic markers and criteria to initiate therapy in Waldenström’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström’s Macroglobulinemia"
    ],
    "type": "article-journal",
    "volume": [
      "30"
    ]
  },
  {
    "author": [
      {
        "family": "Gertz",
        "given": "M.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Am J Hematol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "319–28"
    ],
    "title": [
      "Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on AMyloid and Amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "79"
    ]
  },
  {
    "author": [
      {
        "family": "SV",
        "given": "Rajkumar"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Mayo Clin Proc"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "693–703"
    ],
    "title": [
      "Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis and related plasma cell disorders: diagnosis and treatment"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Wechalekar",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "365–77"
    ],
    "title": [
      "Perspectives in treatment of AL amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "140"
    ]
  },
  {
    "author": [
      {
        "family": "Palladini",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "2936–8"
    ],
    "title": [
      "The association of melphlan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis ineligible for stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Palladini",
        "given": "G."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "5."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "787–8"
    ],
    "title": [
      "Treatment with oral melphalan plus dexamethasone produces longterm resmissions in AL amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "A.",
        "given": "Jaccard"
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "6."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1083–93"
    ],
    "title": [
      "High dose melphalan versus melphalan plus dexamethasone for AL amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "357"
    ]
  },
  {
    "author": [
      {
        "family": "Wechalekar",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "7."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "457–64"
    ],
    "title": [
      "Safety and efficacy of risk-adapted cyclophosphamide, thalidomide and dexamethasone in systemic AL amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Wechalekar",
        "given": "A.D."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "8."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "129"
    ],
    "title": [
      "Efficacy and safety of bortezomib in systemic AL amyloidosis – a preliminary report"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "Sanchorawala",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "9."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "492–6"
    ],
    "title": [
      "Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase II trial"
    ],
    "type": "article-journal",
    "volume": [
      "109"
    ]
  },
  {
    "author": [
      {
        "family": "Commenzo",
        "given": "R.L."
      },
      {
        "family": "Gertz",
        "given": "M.A."
      }
    ],
    "citation-number": [
      "10."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "4276–82"
    ],
    "title": [
      "Autologous stem cell transplantation for primary systemic amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Skinner",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "11."
    ],
    "container-title": [
      "Ann Intern Med"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "85–93"
    ],
    "title": [
      "High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study"
    ],
    "type": "article-journal",
    "volume": [
      "140"
    ]
  },
  {
    "author": [
      {
        "family": "Dispenzieri",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "12."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3960–3"
    ],
    "title": [
      "Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplant: a case control study"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Sanchorawala",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "13."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "3561–3"
    ],
    "title": [
      "Long-term outcome of patients with AL-amyloidosis treated with high-dose melphalan and stem cell transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "110"
    ]
  },
  {
    "author": [
      {
        "family": "Guideline",
        "given": "B.C.S.H./U.K.M.F."
      }
    ],
    "citation-number": [
      "14."
    ],
    "container-title": [
      "Br J Haematol"
    ],
    "note": [
      "Y"
    ],
    "pages": [
      "681–700"
    ],
    "title": [
      "Guidelines on the dignosis and management of AL amyloidosis"
    ],
    "type": "article-journal",
    "url": [
      "http://www.bcshguidelines.com/pdf/ALamyloidosis_210604.pdf"
    ],
    "volume": [
      "125"
    ]
  },
  {
    "author": [
      {
        "family": "Rajkumar",
        "given": "S.V."
      },
      {
        "family": "Gertz",
        "given": "M.A."
      }
    ],
    "citation-number": [
      "15."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "2413–5"
    ],
    "title": [
      "Advances in the treatment of amyloidosis"
    ],
    "type": "article-journal",
    "volume": [
      "356"
    ]
  },
  {
    "note": [
      "Chapter 9 387"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Appendix",
        "suffix": "II"
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Brit J Haematol"
    ],
    "date": [
      "1998"
    ],
    "edition": [
      "third"
    ],
    "pages": [
      "374–78"
    ],
    "title": [
      "Guidelines on oral anticoagulation"
    ],
    "type": "article-journal",
    "volume": [
      "101"
    ]
  },
  {
    "author": [
      {
        "family": "Kearon",
        "given": "C."
      },
      {
        "family": "Hirsh",
        "given": "J."
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "1506–1511"
    ],
    "title": [
      "Management of anticoagulation before and after elective surgery"
    ],
    "type": "article-journal",
    "volume": [
      "336"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 714 CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Beltrami",
        "given": "E.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Clin Microb Rev"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "385–407"
    ],
    "title": [
      "Risk and management of blood-borne infection in healthcare workers"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "author": [
      {
        "family": "Cardo",
        "given": "D.M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "1485–90"
    ],
    "title": [
      "A case-control study of HIV seroconversion in health care workers after percutaneous exposure"
    ],
    "type": "article-journal",
    "volume": [
      "337"
    ]
  },
  {
    "author": [
      {
        "family": "Agency",
        "given": "Health Protection"
      }
    ],
    "citation-number": [
      "3."
    ],
    "date": [
      "2006"
    ],
    "location": [
      "London"
    ],
    "publisher": [
      "HPA"
    ],
    "title": [
      "Eye of the needle: United Kingdom surveillance of significant exposures to bloodborne viruses in healthcare workers"
    ],
    "type": "book"
  },
  {
    "citation-number": [
      "4."
    ],
    "title": [
      "716 CHAPTER 15 Protocols and procedures"
    ],
    "type": null,
    "url": [
      "http://www.clinicalcareoptions.com/upload/hiv/guidelines/uk"
    ]
  },
  {
    "author": [
      {
        "family": "Canellos",
        "given": "G.P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "1992"
    ],
    "note": [
      "N Engl J Med, 327,1478–84."
    ],
    "title": [
      "Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD"
    ],
    "type": null
  },
  {
    "pages": [
      "70–100 109"
    ],
    "type": null
  },
  {
    "title": [
      "• 50% dose reduction if neutrophils 1–1.49 x 109/L and/or platelets 50–70 x 109/L"
    ],
    "type": null
  },
  {
    "title": [
      "• Administer every 3 weeks for 6–8 cycles; follow with 30 Gy radiotherapy to initial sites >5cm and 40 Gy to sites of residual disease"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Diehl",
        "given": "V."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2003"
    ],
    "pages": [
      "2386–95"
    ],
    "title": [
      "Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "348"
    ]
  },
  {
    "citation-number": [
      "718"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Chopra",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1137–45"
    ],
    "title": [
      "The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin’s disease. A single-center eight-year study of 155 patients"
    ],
    "type": "article-journal",
    "volume": [
      "81"
    ]
  },
  {
    "author": [
      {
        "family": "Mills",
        "given": "W."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "588–95"
    ],
    "title": [
      "BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "13"
    ]
  },
  {
    "citation-number": [
      "720"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Fisher",
        "given": "R.I."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1002–6 1"
    ],
    "title": [
      "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "328"
    ]
  },
  {
    "author": [
      {
        "family": "Pfreundshuh",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "634–41"
    ],
    "title": [
      "Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "citation-number": [
      "722"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Dady",
        "given": "P.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Br J Cancer"
    ],
    "date": [
      "1982"
    ],
    "pages": [
      "851–9"
    ],
    "title": [
      "Five years experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "title": [
      "This page intentionally left blank 724 CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Magrath",
        "given": "I."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1996"
    ],
    "pages": [
      "925–34"
    ],
    "title": [
      "Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen"
    ],
    "type": "article-journal",
    "volume": [
      "14"
    ]
  },
  {
    "author": [
      {
        "family": "Lacasce",
        "given": "A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Leuk Lymphoma"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "761–7"
    ],
    "title": [
      "Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity"
    ],
    "type": "article-journal",
    "volume": [
      "45"
    ]
  },
  {
    "author": [
      {
        "family": "Velasquez",
        "given": "W.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "1988"
    ],
    "pages": [
      "117–22"
    ],
    "title": [
      "Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP"
    ],
    "type": "article-journal",
    "volume": [
      "71"
    ]
  },
  {
    "container-title": [
      "J Clin Oncol"
    ],
    "pages": [
      "3633–42"
    ],
    "title": [
      "lymphomas: an 8-year follow-up study of EPOCH"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Wilson",
        "given": "W.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "2685–93"
    ],
    "title": [
      "Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy"
    ],
    "type": "article-journal",
    "volume": [
      "99"
    ]
  },
  {
    "author": [
      {
        "family": "Wilson",
        "given": "W.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2008"
    ],
    "pages": [
      "2717–24"
    ],
    "title": [
      "Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers"
    ],
    "type": "article-journal",
    "volume": [
      "26"
    ]
  },
  {
    "citation-number": [
      "730"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Velasquez",
        "given": "W.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1994"
    ],
    "pages": [
      "1169–76"
    ],
    "title": [
      "ESHAP – an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study"
    ],
    "type": "article-journal",
    "volume": [
      "12"
    ]
  },
  {
    "citation-number": [
      "732"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Hochster",
        "given": "H.S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "987–94"
    ],
    "title": [
      "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and long term follow-up – a report from the Eastern Co-operative Oncology Group"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "author": [
      {
        "family": "Keating",
        "given": "M.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "4079–88"
    ],
    "title": [
      "Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Romaguera",
        "given": "J.E."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "7013–23"
    ],
    "title": [
      "High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high dose MTX and cytarabine"
    ],
    "type": "article-journal",
    "volume": [
      "23"
    ]
  },
  {
    "author": [
      {
        "family": "Thomas",
        "given": "D.A."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Cancer"
    ],
    "date": [
      "2006"
    ],
    "pages": [
      "1569–80"
    ],
    "title": [
      "Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-like lymphoma or acute lymphoblastic leukemia"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "citation-number": [
      "736"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Moskowitz",
        "given": "C.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2001"
    ],
    "pages": [
      "616–23"
    ],
    "title": [
      "A 2-step comprehensive high-dose chemoradiotherapy secondline program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model"
    ],
    "type": "article-journal",
    "volume": [
      "97"
    ]
  },
  {
    "author": [
      {
        "family": "Kewalramani",
        "given": "T."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "3684–8"
    ],
    "title": [
      "Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "author": [
      {
        "family": "Wöhrer",
        "given": "S."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "date": [
      "2005"
    ],
    "genre": [
      "Onkologie 28,73–8."
    ],
    "title": [
      "Effective treatment of indolent non-Hodgkin’s lymphomas with mitoxantrone, chlorambucil and prednisolone"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Herold",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2007"
    ],
    "pages": [
      "1986–92"
    ],
    "title": [
      "Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study"
    ],
    "type": "article-journal",
    "volume": [
      "25"
    ]
  },
  {
    "citation-number": [
      "738"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Ferme",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Ann Onc"
    ],
    "date": [
      "1995"
    ],
    "pages": [
      "543–9"
    ],
    "title": [
      "The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease"
    ],
    "type": "article-journal",
    "volume": [
      "6"
    ]
  },
  {
    "author": [
      {
        "family": "Linch",
        "given": "D.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Lancet"
    ],
    "date": [
      "1993"
    ],
    "pages": [
      "1051–4"
    ],
    "title": [
      "Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomized trial"
    ],
    "type": "article-journal",
    "volume": [
      "341"
    ]
  },
  {
    "author": [
      {
        "family": "Girouard",
        "given": "C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "Ann Oncol"
    ],
    "date": [
      "1997"
    ],
    "pages": [
      "675–80"
    ],
    "title": [
      "Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin’s lymphoma prior to autologous bone marrow transplantation"
    ],
    "type": "article-journal",
    "volume": [
      "8"
    ]
  },
  {
    "citation-number": [
      "740"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Coiffier",
        "given": "B."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "N Engl J Med"
    ],
    "date": [
      "2002"
    ],
    "pages": [
      "235–42"
    ],
    "title": [
      "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "346"
    ]
  },
  {
    "author": [
      {
        "family": "Marcus",
        "given": "R."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "1417–23"
    ],
    "title": [
      "CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma"
    ],
    "type": "article-journal",
    "volume": [
      "105"
    ]
  },
  {
    "citation-number": [
      "742"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "container-title": [
      "Blood"
    ],
    "pages": [
      "4416–23"
    ],
    "title": [
      "lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule"
    ],
    "type": "article-journal",
    "volume": [
      "103"
    ]
  },
  {
    "container-title": [
      "Blood"
    ],
    "pages": [
      "3295–301"
    ],
    "title": [
      "resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial"
    ],
    "type": "article-journal",
    "volume": [
      "108"
    ]
  },
  {
    "author": [
      {
        "family": "McLaughlin",
        "given": "P."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1998"
    ],
    "pages": [
      "2825–33"
    ],
    "title": [
      "Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program"
    ],
    "type": "article-journal",
    "volume": [
      "16"
    ]
  },
  {
    "author": [
      {
        "family": "Byrd",
        "given": "J.C."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "2."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "1999"
    ],
    "pages": [
      "791–5"
    ],
    "title": [
      "Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance"
    ],
    "type": "article-journal",
    "volume": [
      "17"
    ]
  },
  {
    "author": [
      {
        "family": "Sehn",
        "given": "L.H."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "3."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2004"
    ],
    "pages": [
      "1407"
    ],
    "title": [
      "Rapid infusion rituximab in combination with steroid-containing chemotherapy can be given safely and substantially reduces resource utilization"
    ],
    "type": "article-journal",
    "volume": [
      "104"
    ]
  },
  {
    "author": [
      {
        "family": "Ghielmini",
        "given": "M."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "4."
    ],
    "container-title": [
      "Blood"
    ],
    "date": [
      "2005"
    ],
    "pages": [
      "2451"
    ],
    "title": [
      "Infusion speed escalation trial to give full-dose rituximab in one hour without steroids premedication"
    ],
    "type": "article-journal",
    "volume": [
      "106"
    ]
  },
  {
    "citation-number": [
      "744"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "author": [
      {
        "family": "Horning",
        "given": "S.J."
      },
      {
        "others": true
      }
    ],
    "citation-number": [
      "1."
    ],
    "container-title": [
      "J Clin Oncol"
    ],
    "date": [
      "2000"
    ],
    "pages": [
      "972–80"
    ],
    "title": [
      "Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin’s disease: Eastern Cooperative Group Pilot Study E1492"
    ],
    "type": "article-journal",
    "volume": [
      "18"
    ]
  },
  {
    "citation-number": [
      "746"
    ],
    "title": [
      "CHAPTER 15 Protocols and procedures"
    ],
    "type": null
  },
  {
    "genre": [
      "LDH 200–450IU/L Serum phosphate 0.7–1.5mmol/L Serum total protein 63–80g/L Serum urate 0.18–0.42mmol/L Serum G-GT 10–46IU/L Serum iron 14–33mcmol/L",
      "Serum TIBC 45–75mcmol/L Serum ALT 5–42IU/L Serum AST 5–42IU/L Serum free T4 9–24pmol/L Serum TSH 0.35–5.5mU/L Immunology IgG 5.3–16.5g/L IgA 0.8–4.0g/L IgM 0.5–2.0g/L Complement: C3 0.89–2.09g/L C4 0.12–0.53g/L C1 esterase 0.11–0.36g/L CH50 80–120% C-reactive protein <6mg/L Serum B2-microglobulin 1.2–2.4mg/L CSF proteins: IgG 0.013–0.035g/l Albumin 0.170–0.238g/L Urine proteins:"
    ],
    "title": [
      "Table 21.2 Biochemistry and immunology Serum urea 3.0–6.5mmol/L 11.5–16.5g/dL Serum creatinine 60–125 micromol/L Serum sodium 135–145mmol/L Serum potassium 3.5–5.0mmol/v Serum albumin 32–50g/L Serum bilirubin <17micromol/L Serum alk phos 100–300IU/L Serum calcium 2.15–2.55mmol/L Serum"
    ],
    "type": null,
    "volume": [
      "4) 11–28mcmol/L (5"
    ]
  },
  {
    "issue": [
      "11"
    ],
    "note": [
      "Plate 5 Bone marrow showing myeloblasts in AML (b see Fig. 4.1 p.120)."
    ],
    "pages": [
      "82"
    ],
    "title": [
      "Plate 4 Blood film in hereditary spherocytosis. Note: large numbers of dark spherical red cells (b see Fig"
    ],
    "type": null,
    "volume": [
      "2"
    ]
  },
  {
    "note": [
      "Plate 7 AML: myeloblast with large Auer rod (left) (b see Fig. 4.3 p.121)."
    ],
    "pages": [
      "4 2 121"
    ],
    "title": [
      "Plate 6 Bone marrow showing myeloblasts in AML (b see Fig"
    ],
    "type": null
  },
  {
    "note": [
      "b see Fig. 4.6 p.126). Plate 11 Bone marrow: lymphoblasts in ALL L1 (b see Fig. 4.8 p.135)."
    ],
    "title": [
      "Plate 10 Gum hypertrophy in patient with AML"
    ],
    "type": null
  },
  {
    "date": [
      "4.11 p.142"
    ],
    "note": [
      "Plate 15 Blood film in CLL showing smear cells (bottom of field) (b see Fig. 4.12 p.151)."
    ],
    "title": [
      "Plate 14 Peripheral blood film in CML: high power (b see Fig"
    ],
    "type": null
  },
  {
    "note": [
      "in the left superior pubic ramus & ischium (b see p.332)."
    ],
    "title": [
      "Plate 28 MRI of cervical and thoracic spine in a patient with multiple myeloma: substantial extra-osseous mass at T1 displacing the spinal cord anteriorly & causing some cord compression (b see Investigations and diagnosis p.332). Plate 29 Radiograph of pelvis in a patient with multiple myeloma showing abnormal low density bone texture"
    ],
    "type": null
  }
]
